Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

January 19, 2021

Study Completion Date

January 19, 2021

Conditions
Chikungunya
Interventions
BIOLOGICAL

Chikungunya

Virus Like Particle

Trial Locations (2)

20910

Walter Reed Army Institute of Research, Silver Spring

21702

United States Army Medical Research Institute of Infectious Diseases, Fort Deterick

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

Emergent BioSolutions

INDUSTRY

lead

Bavarian Nordic

INDUSTRY